Latest news
MEDIA RELEASE: Feb 14, 2023 05:47 PM
A new tool in the arsenal against COVID-19 is being put to t...
Appearing to ‘blow up’ the SARS-CoV-2 spike protein, a newly discovered class of antibodies shows potential protection against COVID-19 variants.
MEDIA RELEASE: Jan 25, 2023 10:00 AM
Green light for universal COVID-19 vaccine project
A universal vaccine that could bring an end to the COVID-19 pandemic is now in development at the Garvan Institute of Medical Research.
MEDIA RELEASE: Nov 29, 2022 09:01 AM
Rogue immune cells linked to leukaemia are a key driver of a...
Scientists have pinpointed rogue immune cells as a major contributor to autoimmune conditions like rheumatoid arthritis and aplastic anaemia.
May 09, 2022 11:02 AM
Professor Chris Goodnow, Garvan’s Executive Director, recogn...
The American Association of Immunologists has awarded Professor Goodnow with the AAI-BioLegend Herzenberg Award
MEDIA RELEASE: Nov 02, 2021 07:53 AM
Researchers reveal a strategy for next-generation COVID-19 v...
Garvan-led researchers outline a strategy to generate future-proofed COVID-19 vaccines that can resist emergent new viral strains.
Sep 14, 2021 09:28 AM
Garvan Institute receives six NHMRC Investigator Grants
The NHMRC Investigator Grant Scheme will provide $13.5 million in funding to Garvan researchers over the next five years, in recognition of their outstanding track records in research.
Aug 19, 2021 09:03 AM
The unleashed virus defence at the root of a spectrum of dis...
By revealing a new immune defence mechanism, researchers have made future diagnosis easier for patients with rare genetic changes affecting the blood, skin, brain and other organs.
MEDIA RELEASE: Aug 25, 2020 08:23 AM
Flexible targets help immune system make finely-tuned antibo...
An in-depth Garvan study of how the immune system generates effective antibodies provides new insights for vaccine design.
Jul 31, 2020 04:32 PM
Key to treating COVID-19 will be found in our DNA
By Professor Chris Goodnow FAA FRS and first published in The Australian, 31 July 2020.
MEDIA RELEASE: May 21, 2020 10:02 AM
Gene sequencing guides girl’s life-changing arthritis treatm...
Whole genome sequencing at Garvan guided targeted therapy for a child with a severe autoimmune condition.
MEDIA RELEASE: Feb 14, 2020 08:17 AM
Research pinpoints rogue cells at root of autoimmune disease...
Breakthrough cellular genomics technology has allowed Garvan and UNSW Sydney researchers to reveal genetic mutations causing rogue behaviour in the cells that cause autoimmune disease.
MEDIA RELEASE: Sep 19, 2019 08:53 AM
Extinct human species gave modern humans an immunity boost
Garvan researchers have discovered a gene variant that sheds new light on how human immunity was fine-tuned through history.
MEDIA RELEASE: Jul 17, 2019 08:22 AM
A genomic barcode tracker for immune cells
A new research method to pinpoint the immune cells that recognise cancer could significantly change how we treat the disease.
Apr 08, 2019 01:28 PM
Professor Stuart Tangye receives prestigious Presidential Aw...
Professor Stuart Tangye, Leader of Immunity and Inflammatory Diseases research at Garvan, has been awarded the Clinical Immunology Society’s 2019 Presidential Award.
Dec 04, 2018 01:48 PM
Hope grows: finding the cause of autoimmune disease
Type 1 diabetes, multiple sclerosis, lupus, rheumatoid arthritis... all caused by the same disease process – autoimmunity. Garvan’s revolutionary Hope Research project is looking for the root cause.
Nov 01, 2018 09:41 AM
New cellular genomics institute launches
The Garvan-led UNSW Cellular Genomics Futures Institute is set to accelerate research in cellular genomics and single-cell sequencing – and to uncover new targets and treatments for disease.
MEDIA RELEASE: Jul 30, 2018 01:16 PM
My Health Record is an important step towards a healthier fu...
The Garvan Institute of Medical Research considers that My Health Record will
enhance patient care and help transform medical research.
Jun 06, 2018 10:07 PM
Garvan-Weizmann partnership boosted by donation
The potential to uncover personalised treatments for disease has been significantly boosted by a major gift from Bob and Ruth Magid to the Garvan-Weizmann partnership.
MEDIA RELEASE: Apr 13, 2018 06:26 AM
Bad apples made good: the immune system's secret weapon reve...
Cells once thought to be useless – and even a liability – could be important tools in the fight against disease, particularly in vaccines for diseases like HIV
MEDIA RELEASE: Mar 21, 2018 01:00 AM
Visionary researcher Chris Goodnow to take the helm at Garva...
Professor Chris Goodnow, who will succeed Professor John Mattick as Garvan's Executive Director, is one of Australia's most outstanding scientists and an internationally recognised expert in the immune system.
MEDIA RELEASE: Sep 07, 2017 10:48 PM
‘Partner in crime’ mutations work together to kickstart lymp...
Australian researchers have uncovered ‘extraordinary cooperation’ between two DNA mutations that are often found together in lymphomas and leukaemias. The findings help us understand how immune cells can ‘go rogue’, beha...